Categories (sv) Finansiella rapporter - I-Tech

About I-Tech
Investors
Investerare
News & Events
Selektope®
Contact

Aktien
Finansiella rapporter
Prospekt
Presentationer
Finansiell kalender
Ägarförteckning
IR-kontakt
Bolagsstyrning

Prenumerera

Financial Reports
Press releases

Your subscription was successful. Thank you!

Wrong email format, please try again.

Finansiella rapporter

2018

Delårsrapport Q2

2017

Årsredovisning 2017

2016

Årsredovisning 2016

I-Tech AB is a public held bio-technology company based in Mölndal, Sweden that owns all IP and regulatory rights to the antifouling agent Selektope® (generic name, medetomidine). I-Tech also controls the largest and most efficient source of medetomidine production.

Since 2006, I-Tech has successfully transformed the scientific invention of Selektope® into a commercially ready and available antifouling agent.

You can also contact us directly via:
info@i-tech.se or call +46 31 788 05 60.

I-Tech AB
c/o Astra Zeneca AB
Pepparedsleden 1
SE- 431 83 Mölndal
Sweden

Subscribe to receive our latest news

Leave this field empty if you're human: